Get the Stockscreener App
5.76
1.77%
0.10
Mannkind Corp stock is traded at $5.76, with a volume of 1.89M.
It is up +1.77% in the last 24 hours and down -4.64% over the past month.
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
See More
Previous Close:
$5.66
Open:
$5.74
24h Volume:
1.89M
Relative Volume:
0.77
Market Cap:
$1.59B
Revenue:
$248.37M
Net Income/Loss:
$11.74M
P/E Ratio:
115.20
EPS:
0.05
Net Cash Flow:
$18.24M
1W Performance:
+6.27%
1M Performance:
-4.64%
6M Performance:
+6.86%
1Y Performance:
+60.00%
1-Day Range:
$5.675
$5.855
1-Week Range:
$5.36
$5.855
52-Week Range:
$3.47
$7.63
Mannkind Corp Stock (MNKD) Company Profile
Name
Mannkind Corp
Sector
Industry
Phone
818-661-5000
Address
1 CASPER STREET, DANBURY, CA
Compare MNKD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNKD
Mannkind Corp
|
5.76 | 1.59B | 248.37M | 11.74M | 18.24M | 0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Mannkind Corp Stock (MNKD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-25 | Initiated | Wedbush | Outperform |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Dec-19-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-09-24 | Resumed | Leerink Partners | Outperform |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-10-23 | Initiated | Wedbush | Outperform |
| May-14-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-24-19 | Initiated | Oppenheimer | Outperform |
| Oct-25-19 | Initiated | Cantor Fitzgerald | Overweight |
| May-14-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
| Feb-22-19 | Initiated | SVB Leerink | Outperform |
| Feb-28-18 | Downgrade | Maxim Group | Hold → Sell |
| Nov-01-17 | Downgrade | Maxim Group | Buy → Hold |
| Oct-10-17 | Initiated | H.C. Wainwright | Buy |
| Oct-06-17 | Reiterated | Maxim Group | Buy |
| Aug-11-17 | Initiated | Maxim Group | Buy |
| May-10-16 | Reiterated | Piper Jaffray | Underweight |
| May-10-16 | Reiterated | RBC Capital Mkts | Underperform |
| Jan-06-16 | Reiterated | Piper Jaffray | Underweight |
| Jan-06-16 | Reiterated | RBC Capital Mkts | Underperform |
| Nov-04-15 | Downgrade | RBC Capital Mkts | Outperform → Underperform |
| Sep-09-15 | Downgrade | Piper Jaffray | Neutral → Underweight |
| Aug-03-15 | Reiterated | RBC Capital Mkts | Outperform |
| May-11-15 | Downgrade | JP Morgan | Neutral → Underweight |
| May-11-15 | Reiterated | MLV & Co | Hold |
| Apr-16-15 | Reiterated | RBC Capital Mkts | Outperform |
View All
Mannkind Corp Stock (MNKD) Latest News
MannKind: Q2 Earnings Snapshot -August 07, 2024 at 08:09 am EDT - Marketscreener.com
MannKind (MNKD) Expected to Announce Earnings on Tuesday - MarketBeat
Wedbush Initiates Coverage on MannKind (NASDAQ:MNKD) - MarketBeat
MannKind To Present At Oppenheimer Healthcare Life Sciences Conference; Webcast At 11:20 AM ET - Nasdaq
An Analysis of Mannkind Corp (MNKD)’s Potential Price Growth - Knox Daily
MannKind (NASDAQ:MNKD) Coverage Initiated by Analysts at Wedbush - Defense World
Investing in Fortuna Mining Corp (FSM) Is Getting More Attractive - Knox Daily
MannKind Co. (NASDAQ:MNKD) Shares Sold by Calamos Advisors LLC - MarketBeat
There is no doubt that Mannkind Corp (MNKD) ticks all the boxes. - SETE News
MannKind to Present at Upcoming Investor Conferences - Yahoo Finance
MNKD Shares Experience Surge in Value - Knox Daily
Financial Fitness Check: Examining Mannkind Corp (MNKD)’s Key Ratios - The Dwinnex
(02/03/25) Top Picks 2025: MannKind (MNKD) - Moneyshow.com
MNKD Makes Notable Cross Below Critical Moving Average - Nasdaq
MannKind Co. (NASDAQ:MNKD) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
MannKind Co. (NASDAQ:MNKD) Given Consensus Rating of “Buy” by Brokerages - Defense World
Cantor Fitzgerald Estimates MannKind FY2025 Earnings - Defense World
MannKind (NASDAQ:MNKD) Shares Down 3.1%Should You Sell? - MarketBeat
MannKind Co. (NASDAQ:MNKD) Sees Large Drop in Short Interest - MarketBeat
International Assets Investment Management LLC Has $86,000 Position in MannKind Co. (NASDAQ:MNKD) - Defense World
MannKind appoints new EVP as executive plans retirement - Investing.com
MannKind Expands Executive Leadership Team - Yahoo Finance
Here’s Why MannKind Corporation (NASDAQ:MNKD) Is Among the Best Diabetes Stocks to Buy Under $10 - Insider Monkey
10 Best Diabetes Stocks To Buy Under $10 - Insider Monkey
MannKind Announces Upcoming Retirement of Lauren Sabella - TipRanks
MannKind expecting to ‘practically double in size’ with new hires in Danbury - Westfair Online
MannKind Co. (NASDAQ:MNKD) Receives $8.88 Average PT from Analysts - MarketBeat
MannKind Co. (NASDAQ:MNKD) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Franklin Resources Inc. Buys 4,603 Shares of MannKind Co. (NASDAQ:MNKD) - Defense World
Geode Capital Management LLC Has $39.88 Million Stock Holdings in MannKind Co. (NASDAQ:MNKD) - Defense World
MannKind Target of Unusually High Options Trading (NASDAQ:MNKD) - Defense World
MannKind (NASDAQ:MNKD) Stock Price Down 3.1%What's Next? - MarketBeat
Barclays PLC Buys 338,121 Shares of MannKind Co. (NASDAQ:MNKD) - Defense World
Barclays PLC Purchases 338,121 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
Exploring 3 High Growth Tech Stocks In The United States - Yahoo Finance
MannKind (NASDAQ:MNKD) Research Coverage Started at Wells Fargo & Company - Defense World
FY2025 EPS Estimates for MannKind Lowered by Leerink Partnrs - MarketBeat
Leerink Partnrs Decreases Earnings Estimates for MannKind - Defense World
Wells Fargo Initiates Coverage of MannKind (MNKD) with Overweight Recommendation - MSN
MannKind stock up 10% amid bullish Wells Fargo note - MSN
MannKind (NASDAQ:MNKD) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
MannKind (NASDAQ:MNKD) pulls back 3.8% this week, but still delivers shareholders fantastic 36% CAGR over 5 years - Yahoo Finance
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
RBC Capital Upgrades MannKind (MNKD) - MSN
MannKind (NASDAQ:MNKD) Trading Up 5.7%Here's Why - MarketBeat
3 High-Growth Biotech Stocks to Watch - Inkl
MannKind (NASDAQ:MNKD) Upgraded to Outperform at Royal Bank of Canada - MarketBeat
Tyvaso DPI royalties and pipeline potential boost MannKind stock—RBC - Investing.com
FOLD: 3 High-Growth Biotech Stocks to Watch - StockNews.com
Noteworthy Wednesday Option Activity: MNKD, BTU, FSLR - Nasdaq
MannKind (NASDAQ:MNKD) Shares Gap UpShould You Buy? - MarketBeat
Mannkind Corp Stock (MNKD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mannkind Corp Stock (MNKD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Binder Steven B. | Director |
Nov 22 '24 |
Sale |
6.89 |
67,536 |
465,323 |
1,075,026 |
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):